Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Immuno-Oncology Technology|February 2, 2026
Safety and efficacy of immune checkpoint inhibitors in patients with melanoma and pre-existing autoimmune conditions: a systematic review and meta-analysisS Haider, M Hong, J Descallar, et al.
Immuno-Oncology Technology|January 1, 2026
Ligand-receptor interactions of V-domain Ig-containing suppressor of T cell activation and programmed death-1 suppress the anticancer activities of T cellsM Abooali, X Lei, I M Yasinska, et al.
Immuno-Oncology Technology|January 8, 2026
Phase I(b) study evaluating the safety and efficacy of intratumoral agonistic anti-CD40 (selicrelumab) in combination with anti-PD-L1 (atezolizumab) in patients with refractory or relapsed B-cell lymphoma (ITSELF trial)N Alshatti, F Lemonnier, E Bachy, et al.
Immuno-Oncology Technology|December 9, 2025
Longitudinal ctDNA monitoring in patients with metastatic uveal melanoma undergoing isolated hepatic perfusion in combination with ipilimumab and nivolumabM Kadefors, A Nelson, E Blomberg, et al.
Immuno-Oncology Technology|July 24, 2024
Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanomaI A J van Duin, M Schuiveling, L S Ter Maat, et al.
Immuno-Oncology Technology|July 2, 2024
Effect of glucocorticoids for the management of immune-related adverse events on outcome in melanoma patients treated with immunotherapy-a retrospective and biomarker studyF Costa Svedman, M Liapi, A Månsson-Broberg, et al.
Immuno-Oncology Technology|January 12, 2024
Engineering approaches for innate immune-mediated tumor microenvironment remodelingG I Kane, C F Lusi, M L Brassil, et al.
Immuno-Oncology Technology|May 20, 2025
Assessment of CD73 activity in breast cancer-derived small extracellular vesicles: application to monitoring of patients' responses to immunotherapyT L Whiteside, S Sehra, T Chadderton, et al.
Immuno-Oncology Technology|April 24, 2025
Overcoming antigen loss in CAR T therapy with Vγ9Vδ2 CAR T-cellsM Velasco Santiago, P Aehnlich, T M Hulen, et al.
Immuno-Oncology Technology|August 2, 2026
Association between brown adipose tissue activity and clinical outcomes in melanoma: a retrospective PET/CT analysisP Toivanen, P Ketola, T Vahlberg, et al.
Pageof 10